NCT Number: NCT00015340
Buprenorphine/Naloxone in the Treatment of Heroin Dependence - 14
The purpose of this study is the safety and efficacy of Buprenorphine/Naloxone in the treatment of opioid dependence. A compassionate use study.
Looking for future studies?
Notify MeKey information
Conditions
Age range
18 year–59 year
Sex eligibility
All sexes
Study type
Interventional
Phase
Phase 4
Primary location
University of California, Los Angeles, California, United States
About this study
The objective of this study is to provide follow-up compassionate use treatment and evaluate long term safety and efficacy of a buprenorphine/naloxone combination tablet for opiate dependence treatment for subjects who have completed Cooperative Study 1008 A and B.
Who can participate
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Completion of Cooperative Study 1008 A/B
Exclusion criteria
- Significant medical or psychiatric illness. Non-compliance with study procedures in the Cooperative Study 1008 A/B
Treatment and study plan
Primary outcomes
-
Craving
-
Retention
-
Opioid withdrawal
-
Subjective rating
Sponsors and collaborators
Lead sponsor
National Institute on Drug Abuse (NIDA)
Nih
Collaborators
- New York MDRU
Registry information
Official study title
Buprenorphine/Nx Treatment of Heroin Dependence-A Compassionate Use Study
Important dates
- Study start
- 1999
- Primary completion
- 2001
- Study completion
- 2001
- First posted
- Apr 18, 2001
- Registry last updated
- Jan 12, 2017
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
The Efficacy of Methadyl Acetate (LAAM) and Contingency Management Procedures for Treating Dual Opioid and Cocaine Abuse - 1
NCT00158288
Alcohol & Drug Use, Behavior Therapy
West Haven, Connecticut, United States
View Trial DetailsPreliminary Efficacy and Safety of Ibogaine in the Treatment of Methadone Detoxification
NCT04003948
Behavior, Behavior, Addictive
Reus, Tarragona, Spain
View Trial DetailsNaltrexone for Opioid Dependent Released Human Immunodeficiency Virus Positive (HIV+) Criminal Justice Populations
NCT01246401
AIDS, Acquired Immunodeficiency Syndrome
Hartford, Connecticut, United States
View Trial DetailsMethadone Oxytocin Option
NCT01728909
Chemically-Induced Disorders, Mental Disorders
San Francisco, California, United States
View Trial Details